Publications

4895 Results

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-world Experiment

Authors
DD Kim;G Guzauskas;C Bennette;A Basu;D Veenstra;S Ramsey;JJ Carlson
Journal / Conference
PharmacoEconomics Feb;38(2):171-179; 2019 Oct 21. doi: 10.1007/s40273-019-00848-8. [Epub ahead of print]
Year
2020
Research Committee(s)
Breast and Gastrointestinal
PMID
PMID31631254
Study Number(s)
S1513

A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study

Authors
E Schenk;S Mandrekar;G Dy;M Aubry;AD Tan;S Dakhil;TW Wadsworth;B Sachs;J Nieva;C Rudin;J Poitier;JR Molina
Journal / Conference
Journal of Thoracic Oncology Jan;15(1):110-119; 2019 Oct 9 [Epub ahead of print]
Year
2020
Research Committee(s)
Lung
PMID
PMID31605793
PMC
PMC7279615

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307

Authors
JR Gralow;W Barlow;A Paterson;J Miao;D Lew;A Stopeck;D Hayes;D Hershman;M Schubert;M Clemons;C Van Poznak;E Dees;J Ingle;CI Falkson;A Elias;M Messino;J Margolis;S Dakhil;H Chew;K Dammann;J Abrams;R Livingston;G Hortobagyi
Journal / Conference
Journal of the National Cancer Institute Jul 1;112(7):698-707; Oct 31[Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31693129
PMC
PMC7357327
Study Number(s)
S0307

A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients with Advanced/ Metastatic Esophageal, Gastric or Gastroesophageal Junction Cancer Based on Gene Expression of ERCC1: SWOG S1201

Authors
S Iqbal;S McDonough;H-J Lenz;D Ilson;C Nangia;A Barzi;CJ Schneider;J Liu;E Dotan;K Guthrie;H Hochster
Journal / Conference
Journal of Clinical Oncology Feb 10;38(5):472-479
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID31815582
PMC
PMC7007287
Study Number(s)
S1201

Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial

Authors
S Giralt;L Costa;DG Maloney;A Krishnan;M Fei;J Antin;C Brunstein;N Geller;S Goodman;P Hari;B Logan;R Lowsky;M Qazilbash;F Sahebi;G Somlo;S Rowley;D Vogl;D Vesole;M Pasquini;E Stadtmauer
Journal / Conference
Biol Blood Marrow Transplant Apr;26(4):798-804; Nov 19 [Online ahead of print] 2019
Year
2020
Research Committee(s)
Myeloma
PMID
PMID31756536
PMC
PMC7198329

NSABP B-47 / NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy with or without Trastuzumab in High-risk Invasive Breast Cancer Negative for HER2 by ISH and with IHC 1+ or 2+ (HER2-low)

Authors
L Fehrenbacher;R Cecchini;CE Geyer;P Rastogi;J Costantino;JN Atkins;JP Crown;J Polikoff;J-F Boileau;L Provencher;C Stokoe;TD Moore;A Robidoux;PJ Flynn;VF Borges;KS Albain;SM Swain;S Paik;EP Mamounas;N Wolmark
Journal / Conference
Journal of Clinical Oncology Feb 10; 38 (5), 444-453; Dec 10[Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31821109
PMC
PMC7007289

Clinical Outcomes in Women with Early Breast Cancer and a High 21-Gene Recurrence Score of 26-100 Assigned to Receive Adjuvant Chemotherapy plus Endocrine Therapy: A Secondary Analysis of a Prospective Clinical Trial

Authors
JA Sparano;RJ Gray;D Makower;K Pritchard;KS Albain;DF Hayes;CE Geyer;E Dees;M Goetz;JA Olson;T Lively;S Badve;TJ Saphner;LI Wagner;T Whelan;MJ Ellis;S Paik;WC Wood;P Ravdin;MM Keane;HL Gomez Moreno;PS Reddy;T Goggins;I Mayer;A Brufsky;D Toppmeyer;V Kaklamani;J Berenberg;G Sledge
Journal / Conference
JAMA Oncology Mar 1;6(3):367-374; Sep 30[Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31566680
PMC
PMC6777230

Dietary supplement use during chemotherapy and survival outcomes of breast cancer patients enrolled in a cooperative group clinical trial (SWOG S0221)

Authors
C Ambrosone;G Zirpoli;A Hutson;S McCann;W Barlow;KM Kelly;R Cannioto;W McCann;D Hershman;J Unger;HCF Moore;JA Stewart;C Isaacs;TJ Hobday;M Salim;G Hortobagyi;JR Gralow;GT Budd;KS Albain
Journal / Conference
Journal of Clinical Oncology Mar; 38(8):804-814; Dec 19[Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31855498
PMC
PMC7062457
Study Number(s)
S0221

Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

Authors
WA Woodward;W Barlow;R Jagsi;TA Buchholz;S Shak;F Baehner;C Yoshizawa;T Whelan;N Davidson;J Ingle;T King;P Ravdin;CK Osborne;D Tripathy;R Livingston;J Gralow;G Hortobagyi;D Hayes;K Albain
Journal / Conference
JAMA Oncology Apr 1;6(4):505-511; Jan 9 [Online ahead of print]
Year
2020
Research Committee(s)
Breast
PMID
PMID31917424
PMC
PMC6990911
Study Number(s)
SWOG-8814

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: The Neuroendocrine Cohort

Authors
S Patel;M Othus;Y Chae;F Giles;D Hansel;P Singh;A Fontaine;M Shah;A Kasi;T Al Baghdadi;S Vasireddy;E Mayerson;CW Ryan;Melissa Plets;CD Blanke;R Kurzrock
Journal / Conference
Clinical Cancer Research May 15;26(10):2290-2296
Year
2020
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID31969335
PMC
PMC7231627
Study Number(s)
S1609